Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 14.15% is 20% below its 5-year average of 17.77%, near the low end of its 5-year range (13.90%–24.25%).
As of the fiscal period ended Tuesday, June 30, 2026. 18.49% below its 12-month average of 17.36%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
14.15%
OPERATING MARGIN AVG TTM
17.36%
OPERATING MARGIN AVG 3Y
16.80%
OPERATING MARGIN AVG 5Y
17.77%
OPERATING MARGIN AVG 10Y
16.21%
OPERATING MARGIN AVG 15Y
14.67%
OPERATING MARGIN AVG 20Y
15.54%
CURRENT VS TTM AVG
-18.49%
CURRENT VS 3Y AVG
-15.76%
CURRENT VS 5Y AVG
-20.38%
CURRENT VS 10Y AVG
-12.71%
CURRENT VS 15Y AVG
-3.53%
CURRENT VS 20Y AVG
-8.94%
SECTOR MEDIAN · HEALTHCARE
15.61%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-9.35%
vs the sector median at left
Abbott Laboratories
Market Cap
$184.11B
Operating Margin
14.15%
TTM Avg
17.36%
3Y Avg
16.80%
5Y Avg
17.77%
Market Cap
$161.66B
Operating Margin
38.26%
TTM Avg
22.76%
3Y Avg
25.11%
5Y Avg
25.54%
Market Cap
$209.19B
Operating Margin
45.21%
TTM Avg
42.74%
3Y Avg
42.98%
5Y Avg
42.70%
Market Cap
$213.42B
Operating Margin
17.69%
TTM Avg
18.04%
3Y Avg
18.11%
5Y Avg
20.54%
Market Cap
$137.13B
Operating Margin
20.42%
TTM Avg
21.31%
3Y Avg
23.25%
5Y Avg
23.28%
Market Cap
$133.37B
Operating Margin
28.27%
TTM Avg
23.17%
3Y Avg
21.31%
5Y Avg
19.39%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Abbott Laboratories (ABT) | $184.11B | 14.15% | 17.36% | 16.80% | 17.77% |
| Gilead Sciences, Inc. (GILD)vs › | $161.66B | 38.26% | 22.76% | 25.11% | 25.54% |
| Amgen Inc. (AMGN)vs › | $207.87B | 31.63% | 25.38% | 28.78% | 30.08% |
| Novo Nordisk A/S (NVO)vs › | $209.19B | 45.21% | 42.74% | 42.98% | 42.70% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $213.42B | 17.69% | 18.04% | 18.11% | 20.54% |
| Pfizer Inc. (PFE)vs › | $142.54B | 23.45% | 25.29% | 24.23% | 24.05% |
| Danaher Corporation (DHR)vs › | $137.13B | 20.42% | 21.31% | 23.25% | 23.28% |
| Bristol-Myers Squibb Company (BMY)vs › | $133.37B | 28.27% | 23.17% | 21.31% | 19.39% |
| CVS Health Corp. (CVS)vs › | $133.25B | 1.46% | 2.43% | 2.79% | 3.48% |
| AstraZeneca PLC (AZN)vs › | $131.47B | 23.69% | 20.95% | 17.06% | 15.08% |
Gross Margin
56.8%
Operating Margin
14.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 14.15% |
| 2026-03-31 | 16.50% |
| 2025-12-31 | 19.64% |
| 2025-09-30 | 18.09% |
| 2025-06-30 | 18.42% |
| 2025-03-31 | 16.30% |
| 2024-12-31 | 18.13% |
| 2024-09-30 | 17.09% |
| 2024-06-30 | 16.25% |
| 2024-03-31 | 13.90% |
| 2023-12-31 | 18.20% |
| 2023-09-30 | 16.54% |
| 2023-06-30 | 15.14% |
| 2023-03-31 | 14.36% |
| 2022-12-31 | 14.28% |
| 2022-09-30 | 16.36% |
| 2022-06-30 | 20.72% |
| 2022-03-31 | 24.25% |
| 2021-12-31 | 21.34% |
| 2021-09-30 | 23.99% |
| 2021-06-30 | 19.54% |
| 2021-03-31 | 20.40% |
| 2020-12-31 | 22.56% |
| 2020-09-30 | 16.45% |
| 2020-06-30 | 8.76% |
| 2020-03-31 | 10.08% |
| 2019-12-31 | 16.90% |
| 2019-09-30 | 14.88% |
| 2019-06-30 | 14.91% |
| 2019-03-31 | 10.07% |
| 2018-12-31 | 15.14% |
| 2018-09-30 | 13.71% |
| 2018-06-30 | 12.19% |
| 2018-03-31 | 9.08% |
| 2017-12-31 | 9.69% |
| 2017-09-30 | 13.25% |
| 2017-06-30 | 5.85% |
| 2017-03-31 | -1.04% |
| 2016-12-31 | 18.28% |
| 2016-09-30 | 17.31% |
| 2016-06-30 | 15.30% |
| 2016-03-31 | 10.73% |
| 2015-12-31 | 15.71% |
| 2015-09-30 | 13.84% |
| 2015-06-30 | 14.10% |
| 2015-03-31 | 12.46% |
| 2014-12-31 | 15.48% |
| 2014-09-30 | 14.32% |
| 2014-06-30 | 12.20% |
| 2014-03-31 | 6.96% |
| 2013-12-31 | 13.39% |
| 2013-09-30 | 8.81% |
| 2013-06-30 | 11.51% |
| 2013-03-31 | 11.44% |
| 2012-12-31 | 22.29% |
| 2012-09-30 | 3.17% |
| 2012-06-30 | 5.75% |
| 2012-03-31 | 5.38% |
| 2011-12-31 | 20.07% |
| 2011-09-30 | 6.06% |
| 2011-06-30 | 18.44% |
| 2011-03-31 | 14.39% |
| 2010-12-31 | 18.36% |
| 2010-09-30 | 13.61% |
| 2010-06-30 | 18.20% |
| 2010-03-31 | 19.11% |
| 2009-12-31 | 21.20% |
| 2009-09-30 | 21.13% |
| 2009-06-30 | 22.29% |
| 2009-03-31 | 15.79% |
| 2008-12-31 | 21.92% |
| 2008-09-30 | 18.63% |
| 2008-06-30 | 19.23% |
| 2008-03-31 | 16.97% |
| 2007-12-31 | 21.02% |
| 2007-09-30 | 14.53% |
| 2007-06-30 | 18.62% |
| 2007-03-31 | 17.91% |
| 2006-12-31 | -4.08% |
| 2006-09-30 | 12.36% |
| 2006-06-30 | 9.87% |
| 2006-03-31 | 20.53% |
| 2005-12-31 | 21.51% |
| 2005-09-30 | 15.43% |
| 2005-06-30 | 19.82% |
| 2005-03-31 | 21.10% |
| 2004-12-31 | 19.97% |
| 2004-09-30 | 21.84% |
| 2004-06-30 | 16.93% |
| 2004-03-31 | 18.22% |
| 2003-12-31 | 20.00% |
| 2003-09-30 | 16.94% |
| 2003-06-30 | 4.84% |
| 2003-03-31 | 21.41% |
| 2002-12-31 | 18.37% |
| 2002-09-30 | 21.04% |
